| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,701 |
3,442 |
$274K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,081 |
1,005 |
$54K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
342 |
137 |
$14K |
| 99406 |
|
1,209 |
1,127 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
910 |
859 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
46 |
45 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
294 |
290 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
58 |
57 |
$5K |
| 99223 |
Prolong inpt eval add15 m |
41 |
41 |
$5K |
| 93000 |
|
324 |
323 |
$3K |
| 82962 |
|
1,059 |
970 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
266 |
265 |
$2K |
| 99407 |
|
130 |
124 |
$2K |
| 80305 |
|
189 |
181 |
$2K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
15 |
15 |
$919.56 |
| 81003 |
|
269 |
258 |
$474.86 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
611 |
583 |
$449.98 |
| 94010 |
|
24 |
24 |
$442.21 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
21 |
12 |
$422.43 |
| 90688 |
|
18 |
18 |
$346.79 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
56 |
51 |
$325.05 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
153 |
146 |
$261.43 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
35 |
32 |
$243.10 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
16 |
12 |
$213.47 |
| 82044 |
|
38 |
37 |
$176.94 |
| J2010 |
Injection, lincomycin hcl, up to 300 mg |
12 |
12 |
$173.99 |
| 82570 |
|
15 |
15 |
$54.71 |
| 1159F |
|
1,248 |
1,138 |
$3.57 |
| 1034F |
|
797 |
719 |
$0.00 |
| 1036F |
|
795 |
718 |
$0.00 |
| 3074F |
|
930 |
854 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
113 |
109 |
$0.00 |
| 3080F |
|
158 |
148 |
$0.00 |
| 3079F |
|
768 |
717 |
$0.00 |
| 3351F |
|
1,616 |
1,440 |
$0.00 |
| 3075F |
|
298 |
284 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
14 |
14 |
$0.00 |
| 1111F |
|
12 |
12 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
18 |
18 |
$0.00 |
| 99070 |
|
14 |
14 |
$0.00 |
| 3725F |
|
1,466 |
1,312 |
$0.00 |
| 4004F |
|
1,427 |
1,287 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
18 |
18 |
$0.00 |
| 3078F |
|
626 |
585 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
42 |
42 |
$0.00 |
| 3077F |
|
333 |
312 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
87 |
84 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
144 |
139 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
35 |
34 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
18 |
17 |
$0.00 |